Cited by 676Genetic Associations and EpidemiologySchizophrenia research and treatmentBipolar Disorder and Treatment

Psychiatric Genomics: An Update and an Agenda

Open access
Sullivan, Patrick F., Agrawal, Arpana, Bulik, Cynthia M., Andreassen, Ole A., Børglum, Anders D., Breen, Gerome, Cichon, Sven, Edenberg, Howard J. +7 more·2018·American Journal of Psychiatry

Published version of a preprint

Abstract

The Psychiatric Genomics Consortium (PGC) is the largest consortium in the history of psychiatry. This global effort is dedicated to rapid progress and open science, and in the past decade it has delivered an increasing flow of new knowledge about the fundamental basis of common psychiatric disorders. The PGC has recently commenced a program of research designed to deliver "actionable" findings-genomic results that 1) reveal fundamental biology, 2) inform clinical practice, and 3) deliver new therapeutic targets. The central idea of the PGC is to convert the family history risk factor into biologically, clinically, and therapeutically meaningful insights. The emerging findings suggest that we are entering a phase of accelerated genetic discovery for multiple psychiatric disorders. These findings are likely to elucidate the genetic portions of these truly complex traits, and this knowledge can then be mined for its relevance for improved therapeutics and its impact on psychiatric practice within a precision medicine framework. [AJP at 175: Remembering Our Past As We Envision Our Future November 1946: The Genetic Theory of Schizophrenia Franz Kallmann's influential twin study of schizophrenia in 691 twin pairs was the largest in the field for nearly four decades. (Am J Psychiatry 1946; 103:309-322 )].

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2017.17030283

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GWAS of SCZ, BIP, MD, and ADHD from the PGC and other groups have produced many risk loci.

    “Many risk loci have emerged from genome-wide association studies (GWAS) of, amongothers, schizophrenia (SCZ), bipolar disorder (BIP), major depression (MD), and attention-deficit/hyperactivity disorder (ADHD) from the Psychiatric Genomics Consortium (PGC) and other efforts”
  • Psychiatric disorders are highly polygenic, and common variation accounts for a large share of their heritability.

    “Psychiatric disorders are highly polygenic, with a large proportion of heritability contributed by common variation.”
  • The past decade has seen remarkable progress in elucidating the genetic underpinnings of psychiatric disorders, with numerous findings meeting modern criteria for significance and reproducibility.

    “Despite these challenges, there has been remarkable progress in the past decade in elucidating the genetic underpinnings of psychiatric disorders with numerous findings that meet modern criteria for significance and reproducibility (Geschwind and Flint, 2015; Sullivan et al., 2018).”
  • The number of cases is the crucial determinant of the number of loci discovered; increasing sample sizes will identify more loci.

    “The crucial determinant of the number of loci discovered is the number of cases; as sample sizes increase, more loci will be identified (Geschwind and Flint, 2015; Sullivan et al., 2018).”
  • Results to date indicate that psychiatric disorder risk is imparted by many common variants of individually small effects, and several disorders also have contributions from rarer variants with larger impact on risk.

    “The results to date indicate that psychiatric disorder risk is imparted by many common variants of individually small effects, and several disorders also have contributions from rarer variants with larger impact on risk (Geschwind and Flint, 2015; Sullivan et al., 2018).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 34

  1. [1]1. Kendler, KS., Prescott, CA. Genes, Environment, and Psychopathology. New York: Guilford Press; 2006.
  2. [3]3. Kallmann FJ. The genetic theory of schizophrenia: and analysis of 691 schizophrenic twin index families. Am J Psychiatry. 1946; 103:309-322. [PubMed: 20277893]
  3. [4]4. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a metaanalysis of twin studies. Arch Gen Psychiatry. 2003; 60:1187-1192. [PubMed: 14662550]
  4. [5]5. Lichtenstein P, Yip B, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009; 373:234-239. [PubMed: 19150704]
  5. [6]6. Wray NR, Gottesman II. Using summary data from the Danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder. Front Genet. 2012; 3:118. [PubMed: 22783273]
  6. [7]7. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. American journal of human genetics. 2011; 88:76-82. [PubMed: 21167468]
  7. [8]8. Bulik-Sullivan BK, Finucane HK, Anttila V, Gusev A, Day FR, ReproGen Consortium, Psychiatric Genomics Consortium, Anorexia Nervosa Genetic Consortium. Duncan L, Perry JRB, Patterson N, Robinson E, Daly MJ, Price AL, Neale BM. An atlas of genetic correlations across human diseases and traits. Nature Genetics. 2015; 47:1236-1241. [PubMed: 26414676]
  8. [9]9. Psychiatric GWAS Consortium. A framework for interpreting genome-wide association studies of psychiatric disorders. Molecular Psychiatry. 2009; 14:10-17. [PubMed: 19002139]
  9. [10]10. Psychiatric GWAS Consortium. Genome-wide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry. 2009; 166:540-546. [PubMed: 19339359]
  10. [11]11. Cross Disorder Phenotype Group of the Psychiatric GWAS Consortium. Dissecting the phenotype in genome-wide association studies of psychiatric illness. Br J Psychiatry. 2009; 195:97-99. [PubMed: 19648536]
  11. [12]12. Corvin A, Craddock N, Sullivan PF. Genome-wide association studies: a primer. Psychol Med. 2010; 40:1063-1077. [PubMed: 19895722]
  12. [14]14. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, Sangiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science. 2005; 308:385-389. [PubMed: 15761122]
  13. [16]16. WTCCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447:661-678. [PubMed: 17554300]
  14. [21]21. Goldstein JI, Jarskog LF, Hilliard C, Alfirevic A, Duncan LE, Fourches D, Huang H, Lehner T, Lek M, Neale BM, Ripke S, Shianna KV, Szatkiewicz JP, Tropsha A, van den Oord EJCG, Cascorbi I, Dettling M, Gazit E, Goff DC, Holden AL, Kelly DL, Malhotra AK, Nielsen J, Pirmohamed M, Rujescu D, Werge T, Levy DL, Josiassen RC, Kennedy JL, Lieberman JA, Daly MJ, Sullivan PF. Clozapine-induced agranulocytosis/granulocytopenia is associated with rare HLA-DQB1 and HLA-B alleles. Nature communications. 2014; 5:4757.
  15. [23]23. Goldstein DB. Common genetic variation and human traits. N Engl J Med. 2009; 360:1696-1698. [PubMed: 19369660]
  16. [24]24. Malhotra D, Sebat J. CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics. Cell. 2012; 148:1223-1241. [PubMed: 22424231]
  17. [26]26. Cross-Disorder Group of the Psychiatric Genomics Consortium. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature genetics. 2013; 45:984-994. [PubMed: 23933821]
  18. [29]29. Fuchsberger C, Flannick J, Teslovich TM, Mahajan A, Agarwala V, Gaulton KJ, Ma C, Fontanillas P, Moutsianas L, McCarthy DJ, Rivas MA, Perry JR, Sim X, Blackwell TW, Robertson NR, Rayner NW, Cingolani P, Locke AE, Fernandez Tajes J, Highland HM, Dupuis J, Chines PS, Lindgren CM, Hartl C, Jackson AU, Chen H, Huyghe JR, van de Bunt M, Pearson RD, Kumar A, Muller-Nurasyid M, Grarup N, Stringham HM, Gamazon ER, Lee J, Chen Y, Scott RA, Below JE, Chen P, Huang J, Go MJ, Stitzel ML, Pasko D, Parker SC, Varga TV, Green T, Beer NL, DayWilliams AG, Ferreira T, Fingerlin T, Horikoshi M, Hu C, Huh I, Ikram MK, Kim BJ, Kim Y, Kim YJ, Kwon MS, Lee J, Lee S, Lin KH, Maxwell TJ, Nagai Y, Wang X, Welch RP, Yoon J, Zhang W, Barzilai N, Voight BF, Han BG, Jenkinson CP, Kuulasmaa T, Kuusisto J, Manning A, Ng MC, Palmer ND, Balkau B, Stancakova A, Abboud HE, Boeing H, Giedraitis V, Prabhakaran D, Gottesman O, Scott J, Carey J, Kwan P, Grant G, Smith JD, Neale BM, Purcell S, Butterworth AS, Howson JM, Lee HM, Lu Y, Kwak SH, Zhao W, Danesh J, Lam VK, Park KS, Saleheen D, So WY, Tam CH, Afzal U, Aguilar D, Arya R, Aung T, Chan E, Navarro C, Cheng CY, Palli D, Correa A, Curran JE, Rybin D, Farook VS, Fowler SP, Freedman BI, Griswold M, Hale DE, Hicks PJ, Khor CC, Kumar S, Lehne B, Thuillier D, Lim WY, Liu J, van der Schouw YT, Loh M, Musani SK, Puppala S, Scott WR, Yengo L, Tan ST, Taylor HA Jr, Thameem F, Wilson G Sr, Wong TY, Njolstad PR, Levy JC, Mangino M, Bonnycastle LL, Schwarzmayr T, Fadista J, Surdulescu GL, Herder C, Groves CJ, Wieland T, Bork-Jensen J, Brandslund I, Christensen C, Koistinen HA, Doney AS, Kinnunen L, Esko T, Farmer AJ, Hakaste L, Hodgkiss D, Kravic J, Lyssenko V, Hollensted M, Jorgensen ME, Jorgensen T, Ladenvall C, Justesen JM, Karajamaki A, Kriebel J, Rathmann W, Lannfelt L, Lauritzen T, Narisu N, Linneberg A, Melander O, Milani L, Neville M, Orho-Melander M, Qi L, Qi Q, Roden M, Rolandsson O, Swift A, Rosengren AH, Stirrups K, Wood AR, Mihailov E, Blancher C, Carneiro MO, Maguire J, Poplin R, Shakir K, Fennell T, DePristo M, Hrabe de Angelis M, Deloukas P, Gjesing AP, Jun G, Nilsson P, Murphy J, Onofrio R, Thorand B, Hansen T, Meisinger C, Hu FB, Isomaa B, Karpe F, Liang L, Peters A, Huth C, O'Rahilly SP, Palmer CN, Pedersen O, Rauramaa R, Tuomilehto J, Salomaa V, Watanabe RM, Syvanen AC, Bergman RN, Bharadwaj D, Bottinger EP, Cho YS, Chandak GR, Chan JC, Chia KS, Daly MJ, Ebrahim SB, Langenberg C, Elliott P, Jablonski KA, Lehman DM, Jia W, Ma RC, Pollin TI, Sandhu M, Tandon N, Froguel P, Barroso I, Teo YY, Zeggini E, Loos RJ, Small KS, Ried JS, DeFronzo RA, Grallert H, Glaser B, Metspalu A, Wareham NJ, Walker M, Banks E, Gieger C, Ingelsson E, Im HK, Illig T, Franks PW, Buck G, Trakalo J, Buck D, Prokopenko I, Magi R, Lind L, Farjoun Y, Owen KR, Gloyn AL, Strauch K, Tuomi T, Kooner JS, Lee JY, Park T, Donnelly P, Morris AD, Hattersley AT, Bowden DW, Collins FS, Atzmon G, Chambers JC, Spector TD, Laakso M, Strom TM, Bell GI, Blangero J, Duggirala R, Tai ES, McVean G, Hanis CL, Wilson JG, Seielstad M, Frayling TM, Meigs JB, Cox NJ, Sladek R, Lander ES, Gabriel S, Burtt NP, Mohlke KL, Meitinger T, Groop L, Abecasis G, Florez JC, Scott LJ, Morris AP, Kang HM, Boehnke M, Altshuler D, McCarthy MI. The genetic architecture of type 2 diabetes. Nature. 2016; 536:41-47. [PubMed: 27398621]
  19. [33]33. Lek M, Karczewski K, Minikel E, Samocha K, Banks E, Fennell T, O'Donnell-Luria A, Ware J, Hill A, Cummings B, Tukiainen T, Birnbaum D, Kosmicki J, Duncan L, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Cooper D, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki M, Levy-Moonshine A, Natarajan P, Orozco L, Peloso G, Poplin R, Rivas M, Ruano-Rubio V, Ruderfer D, Shakir K, Stenson P, Stevens C, Thomas B, Tiao G, Tusie-Luna M, Weisburd B, Won H-H, Yu D, Altshuler D, Ardissino D, Boehnke M, Danesh J, Roberto E, Florez J, Gabriel S, Getz G, Hultman C, Kathiresan S, Laakso M, McCarroll S, McCarthy M, McGovern D, McPherson R, Neale B, Palotie A, Purcell S, Saleheen D, Scharf J, Sklar P, Sullivan PF, Tuomilehto J, Watkins H, Wilson J, Daly M, MacArthur D. Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016; 536:285-291. [PubMed: 27535533]
  20. [34]34. CNV Working Group of the Psychiatric Genomics Consortium, Schizophrenia Working Groups of the Psychiatric Genomics Consortium. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet. 2016; 49:27-35. [PubMed: 27869829]
  21. [35]35. Singh T, Kurki MI, Curtis D, Purcell SM, Crooks L, McRae J, Suvisaari J, Chheda H, Blackwood D, Breen G, Pietilainen O, Gerety SS, Ayub M, Blyth M, Cole T, Collier D, Coomber EL, Craddock N, Daly MJ, Danesh J, DiForti M, Foster A, Freimer NB, Geschwind D, Johnstone M, Joss S, Kirov G, Korkko J, Kuismin O, Holmans P, Hultman CM, Iyegbe C, Lonnqvist J, Mannikko M, McCarroll SA, McGuffin P, McIntosh AM, McQuillin A, Moilanen JS, Moore C, Murray RM, Newbury-Ecob R, Ouwehand W, Paunio T, Prigmore E, Rees E, Roberts D, Sambrook J, Sklar P, St Clair D, Veijola J, Walters JT, Williams H, Swedish Schizophrenia Study, Interval Study, D. D. D. Study, UK10K Consortium. Sullivan PF, Hurles ME, O'Donovan MC, Palotie A, Owen MJ, Barrett JC. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. Nat Neurosci. 2016; 19:571-577. [PubMed: 26974950]
  22. [36]36. Fromer M, Pocklington AJ, Kavanagh D, Williams H, Dwyer S, Gormley P, Georgieva L, Rees E, Palta P, Ruderfer DM, Carrera N, Humphreys I, Johnson J, Barker DD, Banks E, Milanova V, Grant SG, Hannon E, Rose SA, Chambert K, Mahajan M, Scolnick EM, Moran JL, Kirov G, Palotie A, McCarrol SA, Holmans P, Sklar P, Owen MJ, Purcell SM, O'Donovan M. De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014; 506:179-184. [PubMed: 24463507]
  23. [40]40. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, O'Dushlaine C, Chambert K, Bergen K, Kahler A, Duncan LH, Stahl E, Genovese G, Fernandez E, Collins MO, Komiyama NH, Choudhary JS, Magnusson PKE, Banks E, Shakir K, Garimella K, Fennell T, de Pristo M, Grant SGN, Haggarty SJ, Garbriel S, Scolnick EM, Lander ES, Hultman CM, Sullivan PF, McCarrol SA, Sklar P. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 2014; 506:185-190. [PubMed: 24463508]
  24. [44]44. Breen G, Li Q, Roth BL, O'Donnell P, Didriksen M, Dolmetsch R, O'Reilly PF, Gaspar HA, Manji H, Huebel C, Kelsoe JR, Malhotra D, Bertolino A, Posthuma D, Sklar P, Kapur S, Sullivan PF, Collier DA, Edenberg HJ. Translating genome-wide association findings into new therapeutics for psychiatry. Nat Neurosci. 2016; 19:1392-1396. [PubMed: 27786187]
  25. [48]48. Domingue BW, Belsky D, Conley D, Harris KM, Boardman JD. Polygenic Influence on Educational Attainment: New evidence from The National Longitudinal Study of Adolescent to Adult Health. AERA Open. 2015; 1:1-13. [PubMed: 28164148]
  26. [49]49. Burgess S, Timpson NJ, Ebrahim S, Davey Smith G. Mendelian randomization: where are we now and where are we going? Int J Epidemiol. 2015; 44:379-388. [PubMed: 26085674]
  27. [51]51. Collins AL, Kim Y, Szatkiewicz JP, Bloom RJ, Hilliard C, Quackenbush C, Meier S, Cichon S, Noethen MM, Rietschel M, Sullivan PF. Identifying bipolar disorder susceptibility loci in a densely affected pedigree. Molecular Psychiatry. 2013; 18:1245-1246. [PubMed: 23247078]
  28. [52]52. Roussos P, Mitchell AC, Voloudakis G, Fullard JF, Pothula VM, Tsang J, Stahl EA, Georgakopoulos A, Ruderfer DM, Charney A, Okada Y, Siminovitch KA, Worthington J, Padyukov L, Klareskog L, Gregersen PK, Plenge RM, Raychaudhuri S, Fromer M, Purcell SM, Brennand KJ, Robakis NK, Schadt EE, Akbarian S, Sklar P. A role for noncoding variation in schizophrenia. Cell reports. 2014; 9:1417-1429. [PubMed: 25453756]
  29. [54]54. Pathway Analysis Subgroup of the Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci. 2015; 18:199-209. [PubMed: 25599223]
  30. [55]55. Finucane HK, Bulik-Sullivan BK, Gusev A, Trynka G, Reshef Y, Loh P-R, Anttilla V, Xu H, Zang C, Farh K, Ripke S, Day F, ReproGen Consortium, Schizophrenia Working Group of the Psychiatric Genomics Consortium, RACI Consortium. Purcell S, Stahl EA, Lindstrom S, Perry JRB, Okada Y, Raychaudhuri S, Daly M, Patterson N, Neale BM, Price AL. Partitioning heritability by functional category using GWAS summary statistics. Nature Genetics. 2015; 47:1228-1235. [PubMed: 26414678]
  31. [56]56. Fromer M, Roussos P, Sieberts SK, Johnson JS, Kavanagh DH, Perumal T, Ruderfer DM, Shah HR, Klei LL, Kramer R, Pinto D, Gümüs ZH, CIcek AE, Dang KK, Browne A, Lu C, Readhead - B, Wang Y-C, Mahajan MC, Derry JMJ, Dudley J, Logsdon BA, Talbot K, Zhu J, Zhang B, Sullivan PF, Chess A, Purcell SM, CommonMind Consortium. Shinobu LA, Mangravite LM, Toyoshiba H, Gur RE, Hahn C-G, Lewis DA, Haroutunian V, Peters MA, Lipska BK, Buxbaum JD, Schadt EE, Hirai K, Domenici E, Devlin B, Sklar P. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nature Neuroscience. 2016; 19:1442-1453. [PubMed: 27668389]
  32. [57]57. Akbarian S, Liu C, Knowles JA, Vaccarino FM, Farnham PJ, Crawford GE, Jaffe AE, Pinto D, Dracheva S, Geschwind DH, Mill J, Nairn AC, Abyzov A, Pochareddy S, Prabhakar S, Weissman S, Sullivan PF, State MW, Weng Z, Peters MA, White KP, Gerstein MB, Amiri A, Armoskus C, Ashley-Koch AE, Bae T, Beckel-Mitchener A, Berman BP, Coetzee GA, Coppola G, Francoeur N, Fromer M, Gao R, Grennan K, Herstein J, Kavanagh DH, Ivanov NA, Jiang Y, Kitchen RR, Kozlenkov A, Kundakovic M, Li M, Li Z, Liu S, Mangravite LM, Mattei E, MarkenscoffPapadimitriou E, Navarro FC, North N, Omberg L, Panchision D, Parikshak N, Poschmann J, Price AJ, Purcaro M, Reddy TE, Roussos P, Schreiner S, Scuderi S, Sebra R, Shibata M, Shieh AW, Skarica M, Sun W, Swarup V, Thomas A, Tsuji J, van Bakel H, Wang D, Wang Y, Wang K, Werling DM, Willsey AJ, Witt H, Won H, Wong CC, Wray GA, Wu EY, Xu X, Yao L, Senthil G, Lehner T, Sklar P, Sestan N. The PsychENCODE project. Nat Neurosci. 2015; 18:1707-1712. [PubMed: 26605881]
  33. [59]59. Sanders SJ, He X, Willsey AJ, Ercan-Sencicek AG, Samocha KE, Cicek AE, Murtha MT, Bal VH, Bishop SL, Dong S, Goldberg AP, Jinlu C, Keaney JF 3rd, Klei L, Mandell JD, Moreno-De-Luca D, Poultney CS, Robinson EB, Smith L, Solli-Nowlan T, Su MY, Teran NA, Walker MF, Werling DM, Beaudet AL, Cantor RM, Fombonne E, Geschwind DH, Grice DE, Lord C, Lowe JK, Mane SM, Martin DM, Morrow EM, Talkowski ME, Sutcliffe JS, Walsh CA, Yu TW, Autism Sequencing C, Ledbetter DH, Martin CL, Cook EH, Buxbaum JD, Daly MJ, Devlin B, Roeder K, State MW. Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci. Neuron. 2015; 87:1215-1233. [PubMed: 26402605]
  34. [60]60. Devlin B, Scherer SW. Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev. 2012; 22:229-237. [PubMed: 22463983]

Cited by

Sorted by citations

Authors
Sullivan, P. F., Agrawal, A., Bulik, C. M., Andreassen, O. A., Børglum, A. D., Breen, G., Cichon, S., Edenberg, H. J., Faraone, S. V., Gelernter, J., Mathews, C. A., Nievergelt, C. M., Smoller, J. W., O’Donovan, M. C., & for the Psychiatric Genomics Consortium
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • From the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, Washington University School of Medicine, St Louis; the Norwegian Centre for Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, Oslo; the Lundbeck Foundation Initiative for...
  • Broad Institute (US)
Corresponding author
Sullivan, Patrick F.
Venue
American Journal of Psychiatry
Published
2018-01-01
Volume
175
Issue
1
Pages
15-27
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2609984900
Cited by
676
References
18
Citations by year
2026: 31 · 2025: 46 · 2024: 70 · 2023: 76 · 2022: 78 · 2021: 68 · 2020: 127 · 2019: 101 · 2018: 64 · 2017: 14
FWCI
10.73
Type
journal article
Language
en
Open access
Locations
  • American Journal of Psychiatry (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • JuSER (Forschungszentrum Jülich) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion)
  • Purdue University Indianapolis (Indiana University) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • UNC Libraries
Funders
  • Broad Institute
  • Cohen Veterans Bioscience
  • European Commission (HORIZON2020, 667302, 602805)
  • Science Foundation Ireland
  • Lundbeckfonden (R155-2014-1724, R248‐2017‐2003, U01 MH109528)
  • Universitetet i Bergen
  • H. Lundbeck A/S
  • Gillings School of Public Health
  • Stanley Center for Psychiatric Research, Broad Institute
  • Medical Research Council (MR/P005748/1, MR/L010305/1)
  • National Institute of Mental Health (U01MH109514, MH094421, U01MH109528, U01MH085520, U01MH109536, MH109532, U01MH094421, MH109528, R01MH101519, MH085520, U01MH109532)
  • National Institute on Drug Abuse (K02DA032573)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
Psychiatric Genomics Consortium, psychiatric genetics, open science, therapeutic target, complex traits, precision medicine, genetic discovery
MeSH terms
Pharmacogenomic Variants, Mental Disorders, Humans, Psychiatry, Psychotropic Drugs, Genomics, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review